Breaking News

Cancer patient denied care via Medicare Advantage algorithm; Why aspartame isn't worth worrying about

July 11, 2023
Eros Dervishi for STAT

STAT+ | How UnitedHealth's acquisition of a popular Medicare Advantage algorithm sparked internal dissent over denied care

An investigation of UnitedHealth Group's NaviHealth reveals its algorithm is a focal point for determining Medicare Advantage coverage.

By Casey Ross and Bob Herman


Opinion: Why the aspartame in Diet Coke and Coke Zero probably isn't worth worrying about

Good news for people who enjoy Diet Coke: The evidence for aspartame causing cancer really isn't that compelling.

By Gideon Meyerowitz-Katz


Opinion: How ARPA-H can master the subtle art of risk-taking

ARPA-H has the potential to transform health, ultimately shaping a brighter and more equitable future for all — if it takes the right risks.

By Janika Schmitt and Jacob Swett and Jassi Pannu



More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Enjoying Cancer Briefing? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.

No comments